Medical dermatology company Botanix Pharmaceuticals has commenced trading on the Australian Securities Exchange (ASX) following an oversubscribed financing of A$3.5 million ($2.67 million) and its acquisition by Bone Medical Limited in June 2016.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
